The first tumor suppressor gene described in pancreatic cancer as inactivated by aberrant hypermethylation in its promoter was CDKN2A/p16INK4, which plays a crucial role in inhibiting cell cycle progression the G1 to S phase, ensuring cell cycle arrest [47, 48]. This evidence concerns the gene CDKN2A and neoplasm.